Home / Indicators / Pharmerging markets medicine spending growth vs Sales growth at constant exchange rates Pharmerging markets medicine spending growth vs Sales growth at constant exchange rates In 2026, pharmerging markets medicine spending growth worldwide was 121 billion USD (forecast); sales growth at constant exchange rates was 17.8%.
Change the pair
Compare different indicators
The series
Over time Global, spaced by time
in 2026
. Different units, drawn on separate scales and clipped to the years both
series publish — earlier history stays on each indicator's own page.
Read the values, not the heights.
Pharmerging markets medicine spending growth
Unit: billion USD · 1 observation
Line chart
Pharmerging markets medicine spending growth Pharmerging markets medicine spending growth. 1 observations from 2026–2030 to 2026–2030, ranging from 121 billion USD to 121 billion USD, of which 1 are forecasts.
billion USD
0
30
60
90
120
150
8 Jan
15 Jan
22 Jan
5 Feb
8 Feb
15 Feb
22 Feb
8 Mar
15 Mar
22 Mar
29 Mar
2026
Feb 2026
Mar 2026
FORECAST
121
Pharmerging markets medicine spending growth Pharmerging markets medicine spending growth. 1 observations from 2026–2030 to 2026–2030, ranging from 121 billion USD to 121 billion USD, of which 1 are forecasts.
billion USD
0
50
100
150
8 Jan
15 Jan
22 Jan
8 Feb
15 Feb
22 Feb
8 Mar
15 Mar
22 Mar
29 Mar
2026
Feb 2026
Mar 2026
FORECAST
121
Pharmerging markets medicine spending growth Pharmerging markets medicine spending growth. 1 observations from 2026–2030 to 2026–2030, ranging from 121 billion USD to 121 billion USD, of which 1 are forecasts.
billion USD
0
50
100
150
8 Jan
22 Mar
Feb 2026
Mar 2026
FORECAST
121
View the underlying data Sales growth at constant exchange rates
Unit: % · 2 observations
Line chart Sales growth at constant exchange rates Sales growth at constant exchange rates. 2 observations from Q1 2026 to Q2 2026, ranging from 3% to 17.8%. Latest value 17.8% (Q2 2026).
%
0
5
10
15
20
8 Jan
15 Jan
22 Jan
5 Feb
8 Feb
15 Feb
22 Feb
8 Mar
15 Mar
22 Mar
29 Mar
2026
Feb 2026
Mar 2026
3%
18%
Sales growth at constant exchange rates Sales growth at constant exchange rates. 2 observations from Q1 2026 to Q2 2026, ranging from 3% to 17.8%. Latest value 17.8% (Q2 2026).
%
0
5
10
15
20
8 Jan
15 Jan
22 Jan
8 Feb
15 Feb
22 Feb
8 Mar
15 Mar
22 Mar
29 Mar
2026
Feb 2026
Mar 2026
3%
18%
Sales growth at constant exchange rates Sales growth at constant exchange rates. 2 observations from Q1 2026 to Q2 2026, ranging from 3% to 17.8%. Latest value 17.8% (Q2 2026).
%
0
5
10
15
20
8 Jan
22 Mar
Feb 2026
Mar 2026
3%
18%
View the underlying data Shared periods
Side by side Only one period is
published for both series. Comparing
anything else would mean comparing different years.
Provenance
Where these numbers come from Absolute growth in medicine spending in Pharmerging markets.
3 observations in Global · source
organisations: IQVIA
Percentage change in sales calculated at constant exchange rates over the specified period.
2 observations in Global · source
organisations: Roche, Sanofi
Data published under CC BY 4.0 .
Series A as JSON · Series B as JSON